Brief: Autolus Therapeutics Presents Clinical Data Updates At European Hematology Association Congress
10/06/2022 08:08
June 10 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS PRESENTS CLINICAL DATA UPDATES AT THE
EUROPEAN HEMATOLOGY ASSOCIATION CONGRESS
* AUTO4 SHOWS HIGH LEVEL OF CLINICAL ACTIVITY WITH A NOVEL
TARGETING APPROACH FOR PATIENTS WITH T CELL LYMPHOMA
Source text for Eikon: ID:nGNX7lQtD8
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants